Table 2.
Parent drug | Sample preparation | Chromatography | Interface/Detection | Target analyte | m/z of mass transition | Limit of Detection | Reference |
---|---|---|---|---|---|---|---|
paclitaxel (TAX) | LLE methyl-tert-butyl ether/ACN |
RP C18/gradient HCOONH4/ACN 4.6 × 50 mm, 1.8μm |
ESI+/QTrap | TAX d5-PA |
854/105 859/105 |
0.05 μg/L | [23] |
paclitaxel docetaxel (DE) |
LLE methyl-tert-butyl ether/aqueous MeOH |
RP C18/isocratic MeOH/NH4OH 2.1 × 150 mm, 5μm |
ESI/QQQ/MRM+ | TAX 13C6-PA DE d9-DE |
854/509 860/515 808/527 817/527 |
0.5 μg/L 0.5 μg/L |
[32] |
anthracyclines epirubicin doxorubicin daunoribicin idarubicin |
SPE C18 CH2Cl2/2-propanol |
RP C8/gradient HCOOH/ACN/MeOH 4.6 × 150 mm, 5μm |
ESI/QQQ/MRM+ | EPI DXR DNR IDA epi-IDA |
544/321 544/397 528/321 498/291 528/321 |
0.04 μg/L 0.04 μg/L 0.01 μg/L 0.01 μg/L |
[33] |
Legend of abbreviations used in Table 2. LC/MS determination of taxane and anthracycline drugs in urine.
ACN: acetonitrile, CH2Cl2: methylene chloride, ESI: electrospray ionization, MeOH: methanol, LLE: liquid-liquid extraction, MRM: multiple reaction monitoring, QQQ: triple quadrupole, RP: reversed phase, SPE: solid phase extraction, SRM: single reaction monitoring